Thus, data available to date (both molecular and functional) provide evidence on significantly impaired macrovascular endothelial function in psoriasis patients, possibly induced by the modulation of inflammatory responses (involving TNF-alpha, IL-17A) and increased levels of oxidative stress. This evidence concerns the gene TNF and psoriasis.